Simultaneous use of biologic agents in combination or with Xeljanz may be a viable treatment option for highly selected, refractory patients with inflammatory bowel disease, according to study results. Robert Battat, MD, from...
Read MoreHealio Gastroenterology presents the following reports on the most recent research on inflammatory bowel disease. These reports include new research on the impact of greenspace exposure, gluten intake and yeast commonly found in...
Read MoreDietary gluten intake was not associated with risk for Crohn’s disease or ulcerative colitis, according to study results. Hamed Khalili, MD, MPH, from Massachusetts General Hospital, and colleagues wrote that patients with...
Read MoreMonogenic inflammatory bowel disease, while rare, has varied extra-intestinal comorbidities and limited treatments, according to a study published in Clinical Gastroenterology and Hepatology. “In recent years, the number of...
Read MoreChildhood exposure to residential greenspace was associated with a reduced risk for inflammatory bowel disease, according to data published in the American Journal of Gastroenterology. “Intervention studies designed to target...
Read More
CONCLUSIONS: Based on this post-hoc analysis, infliximab and ustekinumab appear to have similar efficacy and speed of onset in patients with Crohn’s disease who are biologic-naive. Full Text Link:...
Read MoreCONCLUSIONS: Despite the application of rigid selection criteria, ATA cessation remains inadvisable in CD. In contrast, in UC, the concurrent achievement of MH and HH may represent promising selection criteria to identify...
Read MoreINTRODUCTION: Small bowel involvement is very common in Crohn’s disease. Ileocolonoscopy, cross-sectional imaging modalities, and video capsule endoscopy are the tools currently used to investigate such involvement. Full...
Read MoreCONCLUSION: This study indicates a distinct geographical distribution of IBD patients at highest risk for COVID-19 complications in different states of the country, which may reflect contrasting socioeconomic, educational and...
Read MoreCONCLUSION: Our results suggest that CAP effectively induces and maintains steroid-free remission in refractory UC and re-induces steroid-free remission in patients achieving steroid-free remission after the first course of CAP....
Read More